Introduction
MicroRNAs (miRNAs) belong to a family of short noncoding RNAs (�17 to 25 nt in length) that regulate gene expression posttranscriptionally (1) . Perturbation of the endogenous miRNA expression has emerged as one of the most important events in the tumorigenesis of human cancers. Their multigene regulatory capacity enables them to regulate a large fraction of the transcriptome and allows them to emerge as pivotal regulators of gene expression. In profiling studies of cancer miRNA expression, few miRNAs were found to be consistently dysregulated across different tumor types, suggesting their plausible involvement in regulating common cellular processes. These include the recurrent upregulation of miRNAs such as miR-21 (2) and miR-222 (3) and the consistent downregulation of miRNAs including miR-145 (4) and the let7 family (5, 6) . In particular, the progressive downregulation of miR-145 from low-grade to high-grade hepatocellular carcinoma (HCC) (4) parallels that seen in colorectal cancers (7) and breast carcinomas of increasing proliferation index (8) . A plausible role for reduced miR-145 expression in the development of carcinomas with increased proliferative potentials has hence been proposed.
HCC accounts for .80% of all primary liver cancers diagnosed annually and it is one of the most malignant cancers in the Asia and Pacific regions (9) . In an effort to define miRNA expression in HCC, our group and others (3, 4, 10) have described previously on the deregulated pattern of miRNA, of which downregulation of miR-145 represents one of the discriminatory factors in the transition from cirrhosis to tumor (4) . Furthermore, this downregulation of miR-145 is consistently observed irrespective of gender (11) and viral hepatitis infection (type B or C) of patients (3, 4) . Nevertheless, our current understanding on the functional consequences of miR-145 downregulation in HCC is still fragmentary. In the present study, we demonstrated a functional role for miR-145 in the growth and proliferation of HCC cells. We further delineated a causal link between miR-145 downregulation and augmentation of insulin-like growth factor (IGF) signaling. The IGF axis is an important oncogenic pathway of HCC, in which a high percentage of primary HCCs show dysregulation in one or more components of this signaling path (12) , including insulin receptor substrate (IRS)-1 (13, 14) , IRS2 (13, 15) , IRS4 (13), insulin-like growth factor 1 receptor (IGF1R) (13) and IGFII (16) . Furthermore, molecular classification of HCC based on mRNA profiling has categorized the activation of IGF pathway as one of the main molecular subclasses of HCC that contributes to cancer cell proliferation and survival (17) . We showed that miR-145 could inhibit expression of multiple genes along the IGF axis, including IRS1, IRS2 and IGF1R. Our finding also highlights a prognostic value for miR-145 underexpression in predicting a poorer survival prospect of HCC patients.
Materials and methods

Patients
Tumorous liver tissues were collected from 79 patients (HCC#1-HCC#79) who underwent curative surgery for HCC at Prince of Wales Hospital, The Chinese University of Hong Kong. The corresponding adjacent non-tumoral liver tissues were also obtained simultaneously from 73 cases. One ultrasoundguided biopsy specimen (HCC#80) taken from patient who had developed advanced inoperable HCC was also included. Informed consent was obtained from each recruited patient and the study protocol was approved by The Chinese University of Hong Kong -New Territories East Cluster Clinical Research Ethics Committee. All cases were reviewed by pathologist and histologically confirmed as HCC. Ninety percent of the patients in our cohort are hepatitis B virus associated, with 86% of cases having concomitant liver cirrhosis.
Quantitative reverse transcription polymerase chain reaction Total RNA was isolated by TRIzol (Invitrogen, Carlsbad, CA) and treated with RQ1 Rnase-free Dnase (Promega Corporation, Madison, WI) to eliminate genomic DNA carryover. For detecting miR-145 levels, RNA was reverse transcribed to complementary DNA by miR-145-specific reverse transcription primers using MultiScribe reverse transcriptase (Invitrogen). Mature miR-145 levels were determined by Taqman miRNA assays (Invitrogen) using Universal Master Mix without AmpEraseÒ UNG (Invitrogen). Real-time monitoring of fluorescence was performed on the iCycler detection system (Bio-Rad Laboratories, Hercules, CA) with the cycling condition conducted at 95°C for 10 min, followed by 50 cycles of 95°C for 15 s and 60°C for 60 s. Endogenous 18S ribosomal RNA levels were determined simultaneously for normalization using the delta delta Ct method as described previously in other miRNA studies (18, 19) . A miR-145 fold change ratio of 0.67-fold or less (which is equivalent to a reduced level of 1.5-fold or more) was considered downregulation.
Abbreviations: cdc2, cyclin-dependent kinase 2; HCC, hepatocellular carcinoma; IGF, insulin-like growth factor; IGF1R, insulin-like growth factor 1 receptor; IRS, insulin receptor substrate; miRNA, microRNA.
Transfection
The HCC cell line, HKCI-C2, was established from the primary tumor HCC#16, which showed low endogenous miR-145 expression from the quantitative reverse transcription polymerase chain reaction study. Early passage of HKCI-C2 was cultured according to conditions described previously by our group (20) . Transfection efficiency was assessed by flow cytometry and fluorescence microscopy following transfection of a fluorescein isothiocyanateconjugated RNA duplex (Invitrogen). Mature miR-145 mimic, IRS1 small interfering RNA and IRS2 small interfering RNA were acquired from Dharmacon Research (Lafayette, CO). Synthetic oligos, mock1 (cel-miR-67) and mock2 (cel-miR-239b), with no homology to the human genome, were used as negative controls. Thirty-three nanomolar miRNA or small interfering RNA duplex was mediated into cells using Lipofectamine 2000 (Invitrogen) for 6 h following manufacturer's protocol.
Cell viability assay
The effect of miR-145 on cell viability was examined by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide assay at 24 h interval for seven consecutive days. Two thousand transfected HKCI-C2 cells were seeded in a 96-well plate. Cell viability was assayed by incubation of 1 mg/ml 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide for 2 h, and the intensity of formazan formed was measured colorimetrically at 570 nm using Victor Wallac microplate reader (PerkinElmer, Waltham, MA). The experiment was carried out in quintuplicate wells for at least three times.
Colony formation assay
Two thousand transfected HKCI-C2 cells were seeded in a six-well plate and allowed to grow for 7 days. Following ethanol fixation and crystal violet staining, the cultures were photographed using GelDoc System (Bio-Rad) and stained cell colonies were counted by Quantity One v.4.5.2 software (Bio-Rad). The experiment was carried out in triplicate wells for at least three times.
Flow cytometry assay
Transfected HKCI-C2 cells were seeded in 10 cm dishes and harvested at 96 h posttransfection. For cell cycle analysis, ethanol-fixed cells were stained with 50 lg/ml propidium iodide in 3.8 mM sodium citrate and 0.5 lg/ml RNase A. For apoptosis study, cells were stained by a buffer containing fluorescein isothiocyanate Annexin V and propidium iodide following manufacturer's protocol (BD Biosciences, Franklin Lakes, NJ). Flow cytometric study was performed by BD FACSCalibur using CellQuest software. 
Luciferase reporter assay
Each predicted miR-145-binding site was cloned into pMIR-REPORT (Invitrogen) downstream of a firefly luciferase gene driven by a constitutively active cytomegalovirus promoter as recommended by the manufacturer. Mutant constructs of IRS1 site 3 and IRS2 were also generated by introducing mutated nucleotides within the seed region-binding sequences in the oligonucleotides. The sequences of the oligonucleotides used were listed as in Supplementary Table S1 , available at Carcinogenesis Online. The effects of miR-145 on firefly luciferase activity under the control of the putative sites were studied by co-transfection of 500 ng firefly luciferase construct, together with 50 ng Renilla luciferase vector for normalization, into HKCI-C2 cells for 24 h. Synthetic miR-145 was then transfected for 6 h prior to 3 h of resting. Cell lysate was harvested 48 h after luciferase vector transfection and the luciferase reading was measured by Dual luciferase reporter assay (Promega) using GloMaxÒ-multi microplate multimode reader (Promega).
Western blot
Twenty microgram total protein was resolved on 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis, and transferred onto a nitrocellulose membrane (GE Healthcare, Piscataway, NJ). The membrane was then probed with specified primary antibodies as follows: cyclin-dependent kinase 2 (cdc2) (#sc-54, Santa Cruz), cyclin B1 (#AB72, Abcam), cyclin B2 (#sc-28303, Santa Cruz), IRS1 (#2382, Cell Signaling), IRS2 (#06-506, Upstate), IGF1R (#3018, Cell Signaling), active b-catenin (#05-665, Millipore), total b-catenin (#9587, Cell Signaling) and b-actin (#A1978, Sigma-Aldrich). The blots were visualized using ECL chemiluminescence (GE Healthcare).
Immunohistochemistry
Immunohistochemical staining was performed on 33 formalin-fixed paraffinembedded tissue sections of primary HCC. A mouse monoclonal antibody Cases with miR-145 reduction of .1.5-fold were considered as low expression, whereas those with .1.5-fold gain as increased expression. Postoperative data from patients of ,4 months survival were excluded from analysis in both groups. Kaplan-Meier analysis showed that patients with low miR-145 expression correlated with a shorter disease-free survival rate (P , 0.05).
against b-catenin (DAKO, #M3539) was used and mouse immunoglobulin G1 (DAKO, #X0931) served as the negative control. Chromogen development was conducted by ultraview universal Diaminobenzidene detection kit (Ventana Medical System). The overall immunohistochemical grading was categorized into weak, moderate or high, which was scored by multiplying the percentage of positive cells by the staining intensity.
Statistical analysis
Level of miR-145 in HCC tumors and adjacent non-tumoral livers were compared by the Student's t-test. Disease-free survival was analyzed by the Kaplan-Meier method and the statistical probability (P) value was generated by log rank test. The effects of miR-145 on cell proliferation and in luciferase reporter analysis were also assessed by Student's t-test. All data were expressed as mean ± SEM. All statistical analyses were performed using Graphpad Prism, version 3.02. A P-value of ,0.05 was considered to be statistically significant. Figure 1A ). Underexpression of miR-145 in these tumors showed a median reduction of $1.5-fold and minimally detected in 20% (8/40) of cases that showed .10-fold reduction. In Kaplan-Meier survival analysis, we found cases with high miR-145 expressions showed a relatively better prognosis, whereas tumors with lowered miR-145 levels correlated with shorter disease-free survival of patients (P , 0.05) ( Figure 1B) .
Results
Downregulation of miR-145 in primary HCC
Case HCC#16, which showed downregulation of miR-145 expression by near 4-fold compared with its non-tumoral counterpart, was propagated by our group as cell line (20) . This cell line HKCI-C2 was subsequently used throughout this study to investigate the functional roles and signal transductions of miR-145.
Re-expression of miR-145-induced G 2 -M arrest and apoptosis The functional effect of miR-145 has been studied in HKCI-C2 since it exhibits low endogenous miR-145 level that mimics its parental primary tumor (Figure 2Ai ) and a high transfection efficiency of .95% can be attained (Figure 2Aii) . In assessing the effect of miR-145 on cell proliferation, re-expression of miR-145 spontaneously induced marked inhibition on cell viability and colony-forming ability ( Figure 2B ). On day 4 posttransfection, miR-145-transfected HKCI-C2 cells displayed a reduced cell viability by 51.5 ± 6.0% compared with mock controls (P , 0.0001) (Figure 2Bi) . The growth inhibitory effect of miR-145 was further affirmed by an analogous reduction of colony-forming ability by 56.6 ± 4.6% observed in miR-145-transfected cells compared with mock experiments (P , 0.0001) (Figure 2Bii ). (ii) In addition, HKCI-C2 cells showed high transfection efficiencies of .90% as demonstrated by both fluorescence microscopy and flow cytometry. HKCI-C2 was subsequently used throughout this study to investigate the functional role of miR-145. (Bi) Transfection of miR-145 in HKCI-C2 showed consistent diminution of cell viability by .50% relative to mock controls as determined by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide assay. (ii) Colonyforming ability of HKCI-C2 was also significantly reduced upon miR-145 re-expression. Cell viability was expressed as a percentage of maximum absorbance. Ã P , 0.05, ÃÃ P , 0.005, ÃÃÃ P , 0.0005.
miR-145 targets IRS1 and IRS2 in HCC
We further undertook cell cycle analysis and apoptosis assay to examine the mechanism of miR-145-induced growth suppression. Flow cytometric analysis on cell cycle revealed a 32.5 ± 8.0% increase in the proportion of G 2 -M cells in miR-145-transfected group (P , 0.02) (Figure 3Ai ). Examination of key regulators involved in G 2 -M transition indicated a corresponding decrease of cdc2 (Figure 3Aii ), suggesting the possible underlying induction of the growth inhibitory phenotype. Accumulations of cyclin B1 and cyclin B2 proteins were also observed (Figure 3Aii ), which might be the secondary effect from miR-145-induced G 2 -M arrest. Cell cycle histograms of miR-145-transfected cells also demonstrated an induction of sub-G 1 cell population, which is a hallmark of apoptosis (Figure 3Ai ). This prompted us to further carry out Annexin V-propidium iodide staining, which revealed a near 3.5-fold induction in the early apoptotic cell population in miR-145-transfected group (P , 0.002) ( Figure 3B ).
IRS1, IRS2 and IGF1R expressions
The downregulation of cdc2 protein observed in the presence of miR-145 might infer cdc2 as a direct target of miR-145. However, the absence of miR-145-binding motifs on the 3#-untranslated regions of cdc2 negated this hypothesis. We next sought information from in silico algorithms, Targetscan, Miranda, RNAhybrid and Pictar, with particular focus on genes of pathways which have proven importance in HCC. In silico predictions suggested IRS1, a major component of IGF signaling, as a potential downstream target of miR-145 with three putative binding sites located on its 3#-untranslated regions. Other components along the IGF pathway, including IRS2 and IGF1R, were also predicted ( Figure 4A ). Further investigations on the association between IRS1/IRS2/IGF1R and miR-145 demonstrated that the protein levels of these three IGF pathway components were concomitantly downregulated upon miR-145 re-expression ( Figure 4B ).
MiR-145 targeted both IRS1 and IRS2 and elicited IGF signaling cascade Putative miR-145 target sites on IRS1 (sites 1, 2 and 3), IRS2 (site 1) and IGF1R (sites 1 and 2) were cloned downstream of a luciferase gene into reporter plasmid, respectively. Reporter assay showed that exogenous miR-145 exerted repressive effects on luciferase activity of IRS1 site 3 alone by 30% (Figure 4Ci , P 5 0.034), indicating direct association of miR-145 and IRS1 at this perfect 8mer site. Similarly, the putative miR-145 target association on IRS2 site 1 was also confirmed (Figure 4Cii , P 5 0.032). In contrast, only minimal luciferase inhibition could be detected in IGF1R putative sites, albeit a recurring trend was suggested (Supplementary Figure 1 , available at Carcinogenesis Online). We further constructed two mutants for both IRS genes, where Mutant 1 had the entire seed region-binding site mutated and Mutant 2 had partial mutated seed region-binding site. Subsequent luciferase assay demonstrated that the repressive property of miR-145 on IRS1 site 3 and IRS2 site 1 were lost in the mutant constructs ( Figure 5 ), indicating bona fide target association at these specific sites. Functional knockdown of IRS1 and IRS2 in HKCI-C2 showed inhibition on cell viability by 22.2 ± 9.2% and 12.9 ± 2.3%, respectively (P , 0.036) (Figure 6A ), which attest to their role in line with the growth inhibitory phenotype observed from miR-145 re-expression.
It is known that Wnt/ß-catenin activation is a major downstream signaling cascade of IGF pathway (21, 22) . In the analysis of IGF signaling, we showed that re-expression of miR-145 readily inhibited the levels of active ß-catenin in western blotting when using an antibody that specifically binds to ß-catenin dephosphorylated at sites Ser37 and Thr41 ( Figure 6B ). Dephosphorylation at both sites has been shown to protect ß-catenin from GSK-3ß-mediated degradation, which subsequently promotes its nuclear translocation and targets gene transcription. Immunohistochemical studies further affirmed the association of miR-145 reduction and increased ß-catenin staining in 33 primary HCC tumors, although a statistical significance was not suggested (Supplementary Figure 2 , available at Carcinogenesis Online).
Discussion
Altered miRNA expression has been reported in virtually all cancer types, where the occurrence of recurrent deregulated miRNAs emphasizes on the functional importance of these specific miRNAs in tumorigenesis. Underexpression of miR-145 has been described in colorectal, lung, breast, prostate and cervix cancers (8,23-25 ). In HCC, we and others have reported on common downregulations of Western blot analysis revealed that IRS1, IRS2 and IGF1R protein levels were concomitantly reduced upon miR-145 transfection, implying these IGF pathway components might be potential downstream targets. (Ci) Three putative miR-145-binding sites are predicted on the 3#-untranslated regions (3#-UTR) of IRS1, whereas (ii) one 7mer-m8 predicted site is present on IRS2 3#-UTR. MiR-145 significantly reduced the luciferase reading when co-transfected with both (i) IRS1 site 3 plasmid and (ii) IRS2 site 1 plasmid, indicating interaction between miR-145 and IRS1/2 3#-UTR at these specific sites. The other two IRS1 putative binding sites did not show any changes upon co-transfection with miR-145, which inferred no specific interaction of miR-145 at these two sites. Firefly luciferase reading was standardized with Renilla luciferase control. The experiment was conducted in duplicate wells for at least three times with data representing mean ± SEM. miR-145 targets IRS1 and IRS2 in HCC miR-145 targets IRS1 and IRS2 in HCC miR-145 in the hepatic tumors compared with normal liver parenchyma and a progressive diminution of miR-145 from cirrhosis to precursor dysplastic nodules and finally HCC (4) . In this study, we were able to substantiate earlier observations and extended our investigations to determine the functional significance of miR-145 and its potential value as clinical biomarker in HCC. We showed that reduced endogenous miR-145 levels could infer a poorer disease-free survival prospect of patients. This finding may in turn suggest the miR-145 level may be used in combination with other prognostic miRNAs of HCC, including the miR-221-222 cluster (3, 26) , miR-139 (27) and miR-22 (28) to formulate a prognostic signature that may assist guiding postsurgical treatment and decisions about adjuvant therapy.
There are increasing evidences suggesting that miRNAs play an active role in the regulation of many pivotal cancer-inducing pathways (29, 30) . Here, we showed that miR-145 can induce cell cycle arrest and apoptosis in HCC cells, possibly through modulating the IGF signaling pathway. In support of our finding on miR-145 targeting of IRS1, a similar phenomenon has also been described in colorectal cancer (31) . Moreover, we were able to demonstrate in the present study additional modulated components of the IGF axis, including IRS2 and IGF1R. IRSs are adaptor proteins downstream of multiple receptor tyrosine kinases, for instance IGF1R. They themselves do not hold any intrinsic enzymatic activity but rather serve as scaffolds by providing a docking platform for the assembly of multimeric signaling complexes, which in turn allows initiation of intracellular signaling cascades, such as the Wnt/ß-catenin pathway (22) . Members in the IRS protein family, including IRS1, IRS2 and IRS4, have been shown to be associated with cancer development (32) . In line with our observed cell viability inhibiting feature in the presence of IRS1 and IRS2 knockdown, many functional studies have demonstrated that IRSs could contribute to tumorigenesis through promoting uncontrolled proliferation (33, 34) and evasion of apoptosis (16, 35, 36) . Moreover, inhibition of IGF pathway by IGF1R kinase inhibitor (37) or IGF1R-blocking antibody (38) in multiple myeloma and rhabdomyosacroma could hinder tumor cell growth by inducing G 2 -M cell cycle arrest and apoptosis with a concomitant reduction of cdc2 expression. It is therefore probable that miR-145 inhibits HCC cell proliferation along the IGF pathway, at least in part through simultaneous targeting of IRS1 and IRS2, and an indirect influence on IGF1R expression.
Activation of the IGF/IRS/Wnt signaling cascade occurs frequently in HCC oncogenesis (22) . We investigated the effect of miR-145 on the major downstream mediator of the IGF signaling, namely ß-catenin which has known roles in cell growth and expansion of malignant neoplasms (39) . Our analyses demonstrated substantial decrease of active b-catenin level consequential to miR-145 reexpression, which was accompanied by the attenuation of IRS1 and IRS2 expressions. IRS-mediated Wnt/ß-catenin signaling elicitation is exemplified by the findings that IRS1 or IRS2 transgenic mice displayed unique Wnt/ß-catenin-associated histopathological phenotypes and upregulation of ß-catenin target genes, such as cyclin D1 and c-Myc (21). Another study supported IRS1 transgenic mice exhibited significantly elevated Wnt1 and Wnt3 levels, which likely accounted for the Wnt/ß-catenin cascade activation (22) . Taken together, it is plausible that constitutive expression of IRS1, IRS2 and active ß-catenin through miR-145 repression may well have promoted the hepatic malignant growth through the IGF/IRS/Wnt axis.
Our present study substantiates the notion that a single miRNA can coordinate regulation of many components along an oncogenic pathway through its multigene targeting capability. Being a master control of gene expression, a better understanding on the functions of miRNAs in HCC would undoubtedly open new avenues for research in the tumor biology. More importantly, recent technological advances in in vivo delivery of miRNAs (40) will shed new possibilities where tumor-suppressive miRNAs may be utilized in formulating more efficacious therapeutic directions.
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